Doxazosin in combination with atenolol in essential hypertension: a double-blind placebo-controlled multicentre trial

M. Searle, R. Dathan, S. Dean, C. C. Christensen and A. Westheim

View Related Documents

Abstract

Doxazosin (mean dose 11 mg) given once daily in combination with 100 mg atenolol (n=44) was compared with placebo and atenolol (n=43) in a double-blind, multicenter study in patients with mild to moderate essential hypertension.
In the atenolol/doxazosin-treated group, standing blood pressure significantly decreased by 17.0/12.3 mm Hg compared to 6.2/6.7 mm Hg in the atenolol/placebo group whereas supine blood pressure decreased by 13.2/9.8 mm Hg and 9.2/6.0 mm Hg, respectively in the two groups.
Serum lipids did not change significantly in either group. The majority of side-effects reported were mild and transient.
This study confirms that doxazosin may be safely combined with a beta-blocker. Doxazosin proved to be well tolerated and effective in patients with blood pressure refractory to atenolol alone.

Key words  doxazosin - atenolol - hypertension - blood pressure - essential - serum lipids

Fulltext Preview

Image of the first page of the fulltext document